Cargando…
Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
BACKGROUND: We sought to determine which parsimonious combination of complete blood count (CBC)-based biomarkers most efficiently predicts oncologic outcomes in patients undergoing radical cystectomy (RC) for bladder cancer (BC). METHODS: Using our institutional RC database (1992–2012), nine CBC-bas...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815810/ https://www.ncbi.nlm.nih.gov/pubmed/26657651 http://dx.doi.org/10.1038/bjc.2015.432 |
_version_ | 1782424634288766976 |
---|---|
author | Bhindi, Bimal Hermanns, Thomas Wei, Yanliang Yu, Julie Richard, Patrick O Wettstein, Marian S Templeton, Arnoud Li, Kathy Sridhar, Srikala S Jewett, Michael A S Fleshner, Neil E Zlotta, Alexandre R Kulkarni, Girish S |
author_facet | Bhindi, Bimal Hermanns, Thomas Wei, Yanliang Yu, Julie Richard, Patrick O Wettstein, Marian S Templeton, Arnoud Li, Kathy Sridhar, Srikala S Jewett, Michael A S Fleshner, Neil E Zlotta, Alexandre R Kulkarni, Girish S |
author_sort | Bhindi, Bimal |
collection | PubMed |
description | BACKGROUND: We sought to determine which parsimonious combination of complete blood count (CBC)-based biomarkers most efficiently predicts oncologic outcomes in patients undergoing radical cystectomy (RC) for bladder cancer (BC). METHODS: Using our institutional RC database (1992–2012), nine CBC-based markers (including both absolute cell counts and ratios) were evaluated based on pre-treatment measurements. The outcome measures were recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). Time-dependent receiver-operating characteristics curves were used to characterise each biomarker. The CBC-based biomarkers, along with several clinical predictors, were then considered for inclusion in predictive multivariable Cox models based on the Akaike Information Criterion. RESULTS: Our cohort included 418 patients. Neutrophil–lymphocyte ratio (NLR) was the only biomarker satisfying criteria for inclusion into all models, independently predicting RFS (HR per 1-log unit=1.52, 95% CI=1.17–1.98, P=0.002), CSS (HR=1.47, 95% CI=1.20–1.80, P<0.001), and OS (HR=1.56, 95% CI=1.16–2.10, P=0.004). Haemoglobin was also independently predictive of CSS (HR per 1 g/dl=0.91, 95% CI=0.86–0.95, P<0.001) and OS (HR=0.90, 95% CI=0.88–0.93, P<0.001), but not RFS. CONCLUSIONS: Among CBC biomarkers studied, NLR was the most efficient marker for predicting RFS, whereas NLR and haemoglobin were most efficient in predicting CSS and OS. NLR and haemoglobin are promising, cost-effective, independent biomarkers for predicting oncologic BC outcomes following RC. CONDENSED ABSTRACT: Various CBC-based biomarkers have separately been shown to be predictive of oncologic outcomes in patients undergoing cystectomy for BC. Our study evaluated these biomarkers, and determined that NLR is the best CBC-based biomarker for predicting RFS, whereas NLR and haemoglobin are most efficient for predicting CSS and OS. |
format | Online Article Text |
id | pubmed-4815810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48158102017-01-19 Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy Bhindi, Bimal Hermanns, Thomas Wei, Yanliang Yu, Julie Richard, Patrick O Wettstein, Marian S Templeton, Arnoud Li, Kathy Sridhar, Srikala S Jewett, Michael A S Fleshner, Neil E Zlotta, Alexandre R Kulkarni, Girish S Br J Cancer Molecular Diagnostics BACKGROUND: We sought to determine which parsimonious combination of complete blood count (CBC)-based biomarkers most efficiently predicts oncologic outcomes in patients undergoing radical cystectomy (RC) for bladder cancer (BC). METHODS: Using our institutional RC database (1992–2012), nine CBC-based markers (including both absolute cell counts and ratios) were evaluated based on pre-treatment measurements. The outcome measures were recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). Time-dependent receiver-operating characteristics curves were used to characterise each biomarker. The CBC-based biomarkers, along with several clinical predictors, were then considered for inclusion in predictive multivariable Cox models based on the Akaike Information Criterion. RESULTS: Our cohort included 418 patients. Neutrophil–lymphocyte ratio (NLR) was the only biomarker satisfying criteria for inclusion into all models, independently predicting RFS (HR per 1-log unit=1.52, 95% CI=1.17–1.98, P=0.002), CSS (HR=1.47, 95% CI=1.20–1.80, P<0.001), and OS (HR=1.56, 95% CI=1.16–2.10, P=0.004). Haemoglobin was also independently predictive of CSS (HR per 1 g/dl=0.91, 95% CI=0.86–0.95, P<0.001) and OS (HR=0.90, 95% CI=0.88–0.93, P<0.001), but not RFS. CONCLUSIONS: Among CBC biomarkers studied, NLR was the most efficient marker for predicting RFS, whereas NLR and haemoglobin were most efficient in predicting CSS and OS. NLR and haemoglobin are promising, cost-effective, independent biomarkers for predicting oncologic BC outcomes following RC. CONDENSED ABSTRACT: Various CBC-based biomarkers have separately been shown to be predictive of oncologic outcomes in patients undergoing cystectomy for BC. Our study evaluated these biomarkers, and determined that NLR is the best CBC-based biomarker for predicting RFS, whereas NLR and haemoglobin are most efficient for predicting CSS and OS. Nature Publishing Group 2016-01-19 2015-12-10 /pmc/articles/PMC4815810/ /pubmed/26657651 http://dx.doi.org/10.1038/bjc.2015.432 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Molecular Diagnostics Bhindi, Bimal Hermanns, Thomas Wei, Yanliang Yu, Julie Richard, Patrick O Wettstein, Marian S Templeton, Arnoud Li, Kathy Sridhar, Srikala S Jewett, Michael A S Fleshner, Neil E Zlotta, Alexandre R Kulkarni, Girish S Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy |
title | Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy |
title_full | Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy |
title_fullStr | Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy |
title_full_unstemmed | Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy |
title_short | Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy |
title_sort | identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815810/ https://www.ncbi.nlm.nih.gov/pubmed/26657651 http://dx.doi.org/10.1038/bjc.2015.432 |
work_keys_str_mv | AT bhindibimal identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT hermannsthomas identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT weiyanliang identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT yujulie identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT richardpatricko identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT wettsteinmarians identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT templetonarnoud identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT likathy identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT sridharsrikalas identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT jewettmichaelas identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT fleshnerneile identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT zlottaalexandrer identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy AT kulkarnigirishs identificationofthebestcompletebloodcountbasedpredictorsforbladdercanceroutcomesinpatientsundergoingradicalcystectomy |